Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhagyashri D Navalkele

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biologics : Targets & Therapy|February 7, 2018
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent <i>Clostridium difficile</i> infectionBhagyashri D Navalkele, Teena Chopra
Frontiers in Microbiomes|March 19, 2026
Clinical application of live biotherapeutic products in infectious diseasesBhagyashri D Navalkele, Teena Chopra
Open Forum Infectious Diseases|July 16, 2016
Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDIBhagyashri D Navalkele, Stephen A Lerner
Expert Review of Anti-Infective Therapy|August 8, 2017
Candida auris: a worrisome, globally emerging pathogenBhagyashri D Navalkele, Sanjay Revankar, Pranatharthi Chandrasekar
Infection Control and Hospital Epidemiology|July 12, 2021
Increased rates of blood culture contamination during the coronavirus disease 2019 pandemicZerelda Esquer Garrigos, Mary Joyce B Wingler, Petros A Svoronos, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biologics : Targets & Therapy|February 7, 2018
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent <i>Clostridium difficile</i> infectionBhagyashri D Navalkele, Teena Chopra
Frontiers in Microbiomes|March 19, 2026
Clinical application of live biotherapeutic products in infectious diseasesBhagyashri D Navalkele, Teena Chopra
Open Forum Infectious Diseases|July 16, 2016
Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDIBhagyashri D Navalkele, Stephen A Lerner
Expert Review of Anti-Infective Therapy|August 8, 2017
Candida auris: a worrisome, globally emerging pathogenBhagyashri D Navalkele, Sanjay Revankar, Pranatharthi Chandrasekar
Infection Control and Hospital Epidemiology|July 12, 2021
Increased rates of blood culture contamination during the coronavirus disease 2019 pandemicZerelda Esquer Garrigos, Mary Joyce B Wingler, Petros A Svoronos, et al.
Pageof 1